MOST pharmaceutical companies have been exploiting the masses by raising the prices of their products unilaterally and arbitrarily. It is a pity that the regulatory authorities concerned do little in the name of market regulation.

Diabetes is a life-long condition which needs life-long management. Type 1 diabetes is often diagnosed soon after birth. Such people need the administration of insulin injections across their lives. There is no substitute that may do the trick.

Till last year, the insulin that was available for Rs1,000 now costs Rs2,300. What are the pharmaceutical companies up to? Do they want diabetics to die? Surely they do because they know more than the diabetics that there is no alternative available in this case.

Without any support from any quarter, people living with diabetes spend millions of rupees just to be alive.

The pharmaceutical companies, it seems, want the people to spend billions because mere millions are not good enough for their financial balance sheets.

Mansoor ul Haque Solangi
Karachi

Published in Dawn, January 13th, 2023